Generative AI adoption, regulatory scrutiny, DEI policy shifts, real-world evidence, and rare disease economics emerged as key themes across these most-read Applied Clinical Trials articles shaping ...
Migraine Again on MSN
What a pain in the neck: Understanding cervicogenic headache
If you have a headache with neck pain, it could be cervicogenic headache. This article summarizes symptoms and whether ...
A new study published in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center ...
Lisocabtagene maraleucel (liso-cel) shows high response rates in heavily pretreated patients with relapsed or refractory chronic lymphocytic leukemia (CLL), with a CR/CRu rate of 60% and ORR of 83.3%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results